Silicon Investor (SI) -- The First Internet Community

To: CENTrader who wrote (788)	2/16/2000 7:40:00 PM
From: MaxLeverage	Respond to of 1063

Not new , but noteworthy from Exten's site. "The company expects to 1) directly sell devices to hospitals, particularly those with liver transplant programs and 2) set up freestanding outpatient treatment centers much like renal dialysis centers, so that patients can resist or overcome liver disease or poisoning by periodic or short-term treatments. 3) Sell international licensing agreements. The potential market for artificial liver support is projected to be hundreds of millions of dollars annually in the US alone. We intend to offer the most cost-effective and biologically efficient treatment to capture the majority of that market." Now, let's see..door number two looks interesting! exten.com